
Julie Zhen Qin Wu
Examiner (ID: 17059, Phone: (571)272-5205 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1643, 1642 |
| Total Applications | 425 |
| Issued Applications | 229 |
| Pending Applications | 30 |
| Abandoned Applications | 176 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13237037
[patent_doc_number] => 10131710
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-20
[patent_title] => Optimized antibody variable regions
[patent_app_type] => utility
[patent_app_number] => 14/207489
[patent_app_country] => US
[patent_app_date] => 2014-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 181
[patent_figures_cnt] => 186
[patent_no_of_words] => 32725
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14207489
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/207489 | Optimized antibody variable regions | Mar 11, 2014 | Issued |
Array
(
[id] => 10663663
[patent_doc_number] => 20160009807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-14
[patent_title] => 'FUSION IMMUNOMODULATORY PROTEINS AND METHODS FOR MAKING SAME'
[patent_app_type] => utility
[patent_app_number] => 14/771308
[patent_app_country] => US
[patent_app_date] => 2014-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 66
[patent_figures_cnt] => 66
[patent_no_of_words] => 16488
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14771308
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/771308 | Fusion immunomodulatory proteins and methods for making same | Mar 9, 2014 | Issued |
Array
(
[id] => 9757580
[patent_doc_number] => 20140288280
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-25
[patent_title] => 'CYSTEINE ENGINEERED ANTIBODIES AND CONJUGATES'
[patent_app_type] => utility
[patent_app_number] => 14/185080
[patent_app_country] => US
[patent_app_date] => 2014-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 31862
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14185080
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/185080 | CYSTEINE ENGINEERED ANTIBODIES AND CONJUGATES | Feb 19, 2014 | Abandoned |
Array
(
[id] => 10491253
[patent_doc_number] => 20150376274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-31
[patent_title] => 'TREATMENT OF PERIPHERAL T CELL LYMPHOMA'
[patent_app_type] => utility
[patent_app_number] => 14/767600
[patent_app_country] => US
[patent_app_date] => 2014-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 21150
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14767600
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/767600 | Treatment of peripheral T cell lymphoma | Feb 12, 2014 | Issued |
Array
(
[id] => 13635313
[patent_doc_number] => 09844607
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-19
[patent_title] => Immuno imaging agent for use with antibody-drug conjugate therapy
[patent_app_type] => utility
[patent_app_number] => 14/173638
[patent_app_country] => US
[patent_app_date] => 2014-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 20
[patent_no_of_words] => 15019
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14173638
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/173638 | Immuno imaging agent for use with antibody-drug conjugate therapy | Feb 4, 2014 | Issued |
Array
(
[id] => 10489788
[patent_doc_number] => 20150374809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-31
[patent_title] => 'TUMOR VACCINES AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/765266
[patent_app_country] => US
[patent_app_date] => 2014-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13130
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14765266
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/765266 | Tumor vaccines and methods of use thereof | Jan 29, 2014 | Issued |
Array
(
[id] => 14700149
[patent_doc_number] => 10377808
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-13
[patent_title] => High avidity antigen recognizing constructs
[patent_app_type] => utility
[patent_app_number] => 14/763421
[patent_app_country] => US
[patent_app_date] => 2014-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 19
[patent_no_of_words] => 7952
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14763421
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/763421 | High avidity antigen recognizing constructs | Jan 28, 2014 | Issued |
Array
(
[id] => 9771789
[patent_doc_number] => 20140295452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-02
[patent_title] => 'ANTI-CMET ANTIBODY AND ITS USE FOR THE DETECTION AND THE DIAGNOSIS OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/163501
[patent_app_country] => US
[patent_app_date] => 2014-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 20152
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14163501
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/163501 | ANTI-CMET ANTIBODY AND ITS USE FOR THE DETECTION AND THE DIAGNOSIS OF CANCER | Jan 23, 2014 | Abandoned |
Array
(
[id] => 9685313
[patent_doc_number] => 20140242077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-28
[patent_title] => 'METHODS AND COMPOSITIONS FOR MODULATING AN IMMUNE RESPONSE'
[patent_app_type] => utility
[patent_app_number] => 14/162716
[patent_app_country] => US
[patent_app_date] => 2014-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 26965
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14162716
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/162716 | METHODS AND COMPOSITIONS FOR MODULATING AN IMMUNE RESPONSE | Jan 22, 2014 | Abandoned |
Array
(
[id] => 10149069
[patent_doc_number] => 09181346
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-10
[patent_title] => 'Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof'
[patent_app_type] => utility
[patent_app_number] => 14/162208
[patent_app_country] => US
[patent_app_date] => 2014-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 22
[patent_no_of_words] => 25905
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14162208
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/162208 | Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof | Jan 22, 2014 | Issued |
Array
(
[id] => 9569154
[patent_doc_number] => 20140186867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-03
[patent_title] => 'COMPOSITION COMPRISING ANTIBODY THAT BINDS TO DOMAIN II OF HER2 AND ACIDIC VARIANTS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/162255
[patent_app_country] => US
[patent_app_date] => 2014-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 25905
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14162255
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/162255 | COMPOSITION COMPRISING ANTIBODY THAT BINDS TO DOMAIN II OF HER2 AND ACIDIC VARIANTS THEREOF | Jan 22, 2014 | Abandoned |
Array
(
[id] => 9603472
[patent_doc_number] => 20140200155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-17
[patent_title] => 'Prognostic marker for endometrial carcinoma'
[patent_app_type] => utility
[patent_app_number] => 14/155412
[patent_app_country] => US
[patent_app_date] => 2014-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8276
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14155412
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/155412 | Prognostic marker for endometrial carcinoma | Jan 14, 2014 | Abandoned |
Array
(
[id] => 10467176
[patent_doc_number] => 20150352192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-10
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING CANCER'
[patent_app_type] => utility
[patent_app_number] => 14/760672
[patent_app_country] => US
[patent_app_date] => 2014-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 14084
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14760672
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/760672 | Methods and compositions for treating cancer | Jan 12, 2014 | Issued |
Array
(
[id] => 14171735
[patent_doc_number] => 10259863
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-16
[patent_title] => Bovine fusion antibodies
[patent_app_type] => utility
[patent_app_number] => 14/760115
[patent_app_country] => US
[patent_app_date] => 2014-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 14
[patent_no_of_words] => 51867
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14760115
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/760115 | Bovine fusion antibodies | Jan 9, 2014 | Issued |
Array
(
[id] => 11218855
[patent_doc_number] => 09447184
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-20
[patent_title] => 'IL-1 binding proteins'
[patent_app_type] => utility
[patent_app_number] => 14/141317
[patent_app_country] => US
[patent_app_date] => 2013-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 92131
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14141317
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/141317 | IL-1 binding proteins | Dec 25, 2013 | Issued |
Array
(
[id] => 9616998
[patent_doc_number] => 20140206852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-24
[patent_title] => 'SIGNAL-SENSOR POLYNUCLEOTIDES'
[patent_app_type] => utility
[patent_app_number] => 14/135876
[patent_app_country] => US
[patent_app_date] => 2013-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 184179
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14135876
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/135876 | SIGNAL-SENSOR POLYNUCLEOTIDES | Dec 19, 2013 | Abandoned |
Array
(
[id] => 9560673
[patent_doc_number] => 20140178386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-26
[patent_title] => 'FUNCTIONALIZED POLYPEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 14/134988
[patent_app_country] => US
[patent_app_date] => 2013-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8253
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14134988
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/134988 | Functionalized polypeptides | Dec 18, 2013 | Issued |
Array
(
[id] => 12247358
[patent_doc_number] => 09920124
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-20
[patent_title] => 'Methods of producing immunoconjugates'
[patent_app_type] => utility
[patent_app_number] => 14/654384
[patent_app_country] => US
[patent_app_date] => 2013-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 19976
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14654384
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/654384 | Methods of producing immunoconjugates | Dec 18, 2013 | Issued |
Array
(
[id] => 9615706
[patent_doc_number] => 20140205562
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-24
[patent_title] => 'IL-1 BINDING PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 14/133380
[patent_app_country] => US
[patent_app_date] => 2013-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 92059
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14133380
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/133380 | IL-1 binding proteins | Dec 17, 2013 | Issued |
Array
(
[id] => 9634819
[patent_doc_number] => 20140212925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-31
[patent_title] => 'IL-1 BINDING PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 14/109606
[patent_app_country] => US
[patent_app_date] => 2013-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 92215
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14109606
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/109606 | IL-1 binding proteins | Dec 16, 2013 | Issued |